Bhavesh C. Variya

Bhavesh C. Variya

Auto-generated profile, based on publicly available information

Bhavesh C. Variya

Department of Pharmacology, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat, India

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2013 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
VPVipul D Prajapati
Vipul D Prajapati
GJGirish K. Jani
Girish K. Jani
NMNaresh G. Moradiya
Naresh G. Moradiya
NRNarayan P. Randeria
Narayan P. Randeria
BNBhanu J. Nagar
Bhanu J. Nagar
BVBhavesh C. Variya
Bhavesh C. Variya

1 September 2016 in Pharmacological Research
Verified
Journal Article
Closed access
BVBhavesh C. Variya
Bhavesh C. Variya
ABAnita K. Bakrania
Anita K. Bakrania
SPSnehal Patel
Snehal Patel

1 August 2016 in Bioorganic Chemistry
Verified
Journal Article
Closed access
PSPavan Srivastava
Pavan Srivastava
VVVivek K. Vyas
Vivek K. Vyas
BVBhavesh Variya
Bhavesh Variya
PPPalak Patel
Palak Patel
GQGulamnizami Qureshi
Gulamnizami Qureshi
MGManjunath Ghate
Manjunath Ghate

1 September 2016 in Pharmacological Research
Verified
Journal Article
Closed access
ABAnita K. Bakrania
Anita K. Bakrania
BVBhavesh C. Variya
Bhavesh C. Variya
SPSnehal Patel
Snehal Patel

1 April 2017 in European Journal of Pharmacology
Verified
Journal Article
Closed access
JSJignasa Savjani
Jignasa Savjani
SMSuja Mulamkattil
Suja Mulamkattil
BVBhavesh Variya
Bhavesh Variya
SPSnehal Patel
Snehal Patel

1 December 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
BVBhavesh C. Variya
Bhavesh C. Variya
ABAnita K. Bakrania
Anita K. Bakrania
YCYuanli Chen
Yuanli Chen
JHJihong Han
Jihong Han
SPSnehal Patel
Snehal Patel
Since ancient time, Emblica officinalis (E. officinalis) is being used for the management of various ailments. Phytochemical analysis proves that fruit juice of E. officinalis contains high amount gallic acid, which could be responsible for medicinal potentials. Hence in this study, gallic acid and fruit juice of E. officinalis were evaluated for anti-hyperlipidemic potential in various experimental animal models. Experimentally, hyperlipidemia was induced through administration of poloxamer-407, tyloxapol and high-fat-diet supplement in rats. Treatment with gallic acid as well as fruit juice of E. officinalis decreased plasma cholesterol and reduced oil infiltration in liver and aorta. Mechanistically, E. officinalis increased peroxisome proliferator-activated receptors-α (PPARα) expression and increased activity of lipid oxidation through carnitine palmitoyl transferase (CPT) along with decreased activity of hepatic lipogenic enzymes i.e. glucose-6-phosphate dehydrogenase (G6PD), fatty acid synthase (FAS) and malic enzyme (ME). Additionally, E. officinalis increased cholesterol uptake through increased LDL-receptor expressions on hepatocytes and decreased LDL-receptor degradation due to decreased proprotein convertase subtilisin/kexin type 9 (PCSK9) expression. Simultaneously, E. officinalis showed ability to restore glucose homeostasis through increased Glut4 and PPARγ protein expression in adipose tissue. These findings exposed central role of gallic acid in E. officinalis arbitrated anti-hyperlipidemic action through upregulation of PPARs, Glut4 and lipogenic enzymes, and decreased expression of PCSK9 and lipogenic enzymes. Findings from this experiment demonstrated that E. officinalis is a potential therapy for management of hyperlipidemia and gallic acid could be a potential lead candidate.